Clinical Trials Browser

Phase 2 × Terminated × Digoxin × Clear all

NCT04141995 2025-08-07

FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer

Phase 2 Terminated

Gastrointestinal

Pancreatic Neoplasms

NCT00281021 2018-03-29

Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer

Phase 2 Terminated

26 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung

NCT01887288 2018-02-22

Capecitabine With Digoxin for Metastatic Breast Cancer

Phase 2 Terminated

16 enrolled 1 chart

Breast Neoplasms